Advertisement

Home / Health / Renowned Journalist Christiane Amanpour Battles Ovarian Cancer for Third Time

Renowned Journalist Christiane Amanpour Battles Ovarian Cancer for Third Time

Summary

  • Christiane Amanpour's ovarian cancer has returned for the third time
  • She is undergoing successful immunotherapy treatment with no side effects
  • Amanpour credits her support system for sustaining her during the illness
Renowned Journalist Christiane Amanpour Battles Ovarian Cancer for Third Time

Renowned international journalist and news anchor Christiane Amanpour, 67, is navigating her battle with ovarian cancer for the third time. In a recent podcast appearance, Amanpour announced that her cancer has returned, but she is undergoing successful immunotherapy treatment with no side effects.

Amanpour, who was first diagnosed in May 2021, explained that her cancer is a rare type, making up less than 10% of cases. She has undergone major surgery and 18 weeks of chemotherapy in the past. Now, Amanpour takes daily pills and receives hospital infusions every six weeks as part of her immunotherapy regimen.

Despite the challenges, Amanpour expressed gratitude for the support she has received from her family, friends, and colleagues. She said, "It really sustained me because it's not just the illness, it's the state of mind. And to have all these people who just literally every day were asking me how I was, how they could help...the community is actually vital and I'm just so very lucky that I had that."

Advertisement

Amanpour's cancer was detected early thanks to her routine check-ups every three months, which she credits as a "superb insurance policy." She hopes her story will raise awareness about the importance of early detection for ovarian cancer, which is often referred to as the "invisible killer."

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.

Advertisement

Christiane Amanpour is battling a rare type of ovarian cancer, which makes up less than 10% of cases.
Amanpour is undergoing successful immunotherapy treatment, which she says has been "the opposite of grueling" and has had no side effects. She takes daily pills and receives hospital infusions every six weeks as part of her treatment.
Amanpour credits the support of her family, friends, and colleagues for sustaining her during this challenging time. She said, "It really sustained me because it's not just the illness, it's the state of mind. And to have all these people who just literally every day were asking me how I was, how they could help...the community is actually vital and I'm just so very lucky that I had that."

Read more news on